Sort
10,766 grants matching “checkpoint inhibitor”
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$549,873Paul E Kinahan · University Of Washington · U24 · FY2024 · CA
Systems Biology of Glycosylation
$549,809Sriram Neelamegham · State University Of New York At Buffalo · R01 · FY2023 · HL
Systems Biology of Glycosylation
$549,809Sriram Neelamegham · State University Of New York At Buffalo · R01 · FY2022 · HL
Systems Biology of Glycosylation
$549,809Sriram Neelamegham · State University Of New York At Buffalo · R01 · FY2025 · HL
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$549,519Gerald V Denis · Boston University Medical Campus · U01 · FY2023 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Stromal Regulation of Basal Cell Carcinoma Formation
$549,316Anthony E Oro · Stanford University · R01 · FY2023 · AR
Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
$549,292Jun Wang · New York University School Of Medicine · R01 · FY2024 · CA
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$549,102Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors
$548,962Toru Miki · Basic Sciences · Z01 · FY2007 · CA
CLINICAL TRIALS OF FLAVOPIRIDOL WITH CHEMOTHERAPY
$548,956Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$548,908Adam I Marcus · Emory University · P01 · FY2022 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$548,899Zihai Li · Ohio State University · R01 · FY2025 · CA
Developing new therapeutic strategies for brain metastasis
$548,753Eva Hernando · New York University School Of Medicine · R01 · FY2025 · CA
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer
$548,628Janet Anne Houghton · Southern Research Institute · R01 · FY2016 · CA
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer
$548,628Rebecca Boohaker · Southern Research Institute · R01 · FY2017 · CA
Targeting GLI-dependent Transcription by GANT61 in Colon Cancer
$548,628Rebecca Boohaker · Southern Research Institute · R01 · FY2018 · CA
Role of meningeal lymphatic vasculature in neuroimmune communication development
$548,579Jean-Leon Thomas · Yale University · R01 · FY2024 · NS
Expanding the cancer paralog genetic interaction map to enable precision oncology
$548,562Alice Berger · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2021 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2019 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2020 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2018 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2022 · NS